ZBIO
Morgan Stanley’s ProShares UltraPro Short NASDAQ Biotechnology ZBIO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-1,905
| Closed | -$17K | – | 6863 |
|
|
2019
Q4 | $17K | Buy |
1,905
+1,844
| +3,023% | +$16.5K | ﹤0.01% | 6147 |
|
|
2019
Q3 | $1K | Sell |
61
-931
| -94% | -$15.3K | ﹤0.01% | 6602 |
|
|
2019
Q2 | $13K | Buy |
992
+768
| +343% | +$10.1K | ﹤0.01% | 6071 |
|
|
2019
Q1 | $3K | Sell |
224
-6,362
| -97% | -$85.2K | ﹤0.01% | 6426 |
|
|
2018
Q4 | $145K | Buy |
6,586
+6,578
| +82,225% | +$145K | ﹤0.01% | 5412 |
|
|
2018
Q3 | $0 | Sell |
8
-1
| -11% | – | ﹤0.01% | 6896 |
|
|
2018
Q2 | $0 | Sell |
9
-1,568
| -99% | – | ﹤0.01% | 6823 |
|
|
2018
Q1 | $16K | Buy |
1,577
+1,242
| +371% | +$12.6K | ﹤0.01% | 6177 |
|
|
2017
Q4 | $3K | Sell |
335
-426
| -56% | -$3.82K | ﹤0.01% | 6419 |
|
|
2017
Q3 | $7K | Sell |
761
-317
| -29% | -$2.92K | ﹤0.01% | 6247 |
|
|
2017
Q2 | $14K | Buy |
1,078
+893
| +483% | +$11.6K | ﹤0.01% | 6172 |
|
|
2017
Q1 | $3K | Buy |
+185
| New | +$3K | ﹤0.01% | 6434 |
|
|
2016
Q3 | – | Sell |
-5,590
| Closed | -$181K | – | 6607 |
|
|
2016
Q2 | $181K | Sell |
5,590
-5,148
| -48% | -$167K | ﹤0.01% | 4991 |
|
|
2016
Q1 | $389K | Buy |
10,738
+9,361
| +680% | +$339K | ﹤0.01% | 4592 |
|
|
2015
Q4 | $28K | Buy |
+1,377
| New | +$28K | ﹤0.01% | 5933 |
|